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1. Introduction
Stroke is one leading cause of morbidity and mortality worldwide, with acute ischemia
constituting approximately 80% of all cases (Srinivasan et al. 2006). In the past imaging was
primarily used to exclude hemorrhage and other causes. Yet diagnostic classification and
clinical prognosis are major challenges in acute stroke. This is of particular importance since
the approval of intravenous tissue plasminogen activator therapy for acute ischemic stroke
within a narrow therapeutic window of 4.5 hours (Hacke et al. 2008; Wahlgren et al. 2008). It
then becomes clear that advance imaging techniques would be much needed to identify this
subgroup of patient who could be beneficial for thrombolytic therapy.
Computed tomography (CT) scan has been the traditional method for acute stroke imaging
with excellent sensitivity for acute intracerebral hemorrhage, but demonstrates limited
sensitivity for detection of ischemic infarction, with a reported sensitivity of 40-60% only
within 6 hours of onset, and a negative predictive valve of 17% (von Kummer et al. 2001).
Magnetic resonance (MR) imaging has no doubt superior spatial and contrast resolution as
compared with CT, achieving higher sensitivity and accuracy. It has even emerged over last
few years to become as sensitive as CT in depiction of acute intracranial hemorrhage (Fiebach
et al. 2004; Kidwell et al. 2004). Perfusion-weighted imaging (PWI) and diffusion-weight
imaging (DWI) had played an influencing role since their introduction in late 1980s. Applica‐
tion DWI and PWI offer complex information regarding infarction and perfusion deficits,
significantly improving the diagnostic yield. In a recent meta-analysis, Schellinger et al.
(2010) found that the ability to correctly diagnose acute ischemic stroke on MR was signifi‐
cantly higher than CT, demonstrating an odds ratio of 25 (p<0.0001; confidence interval: 8-79).
It also brings forward the concept of salvageable brain tissue as indicated by penumbra which
is a rather dynamic entity that exists within a narrow range of perfusion pressures, carrying
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significant implication on therapy selection and prediction of clinical outcome. The goal is to
salvage the ischemic but viable penumbral tissue from progression into infarction.
2. Diffusion-weighted imaging
In DWI, the random motion or diffusion pulse of water molecules in a tissue compartment
through a magnetic field gradient causes phase shifting leading to intravoxel dephasing and
hence loss of signal intensity (Poustchi-Amin et al. 2001). In region of acute infarct or irrever‐
sible ischemia, the decreased diffusion of water molecules due to presence of cytotoxic edema
(neuronal and glial cell swelling) from intracellular water accumulation and disruption of
membrane ionic homeostasis will manifest as an increase in signal intensity, reflecting a
decrease in apparent diffusion coefficient (ADC). ADC is “apparent” only because the actual
measurement cannot be obtained by DWI due to presence of unmeasured variables that
influence the rate of diffusion, such as temperature of the tissue and actual route of the
diffusing molecule. Images are acquired sequentially with the axis of diffusion sensitization
in three orthogonal planes, with their average yielding an image with minimal anisotropy-
related hyperintensity. As a result, infracted tissue appears bright in comparison with normal
bran tissue. This has significant impact in helping to identify area of acute ischemia from
chronic ischemic, and hence stratify treatment plan.
 
(a) DWI (b) ADC 
map 
Figure 1. a) DWI shows hyperintense signal along bilateral posterior cerebral arterial territories. b) corresponding ADC
map demonstrates hypointense signal.
In  human,  restricted  diffusion  showing increased DWI signal  with  reduced ADC value
(Figure 1) have been observed as early as 30 minutes after onset of ischemia (Srinivasan et
al.  2006).  ADC continues to decrease for 3-5 days, reaching its minimum value of about
50% between 24-48 hours after symptoms onset before returning to baseline at approximate‐
ly 1-4 weeks, so called pseudonormalization. At this stage, mildly hyperintense DWI signal
with normalized ADC value will be seen. ADC increases afterwards with value higher than
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normal  value  associated  with  variable  DWI  signal  (from  T2  effect)  for  upto  months,
presumably related to increased quantity of extracellular water. It is important to note that
DWI signal  can remain hyperintense  for  a  long period (initially  due to  restricted diffu‐
sion but latter due to T2 shine-through effect) and cannot reliably estimate infarct age alone,
while reduced ADC value almost always point to acute infarction. Yet,  tissue with very
low ADC value  may recover  and no  single  threshold  can  distinguish  salvageable  from
unsalvageable tissue (Fiehler et al. 2002). Therefore we must interpret DWI with ADC maps
together cautiously.
DWI-ADC carries high sensitivity (88-100%) and specificity (86-100%) in depiction of acute
ischemia (Beaulieu et al. 1999; Gonzalez et al. 1999; Lövblad et al. 1997, 1998). However, with
increasing cases of DWI-negative stroke reported and bearing in mind the existence of patient
selection bias in the reported series, the true sensitivity probably lies between 80%-90% in
general (Schellinger et al. 2010). In a prospective randomized study comparing between DWI
and CT scan in evaluation of acute ischemic stroke, Fiebach et al. (2002) reported that the
sensitivity of infarct detection was significantly better based on DWI (91%) than on CT (61%),
achieving good interrater homogeneity and better accuracy even for readers with limited
experience. This is due to relative insensitivity of CT for ischemia beyond 10ml per 100/min.
as compared with DWI (Barber et al. 1999). False negative is unusual but is generally more
common in posterior fossa stroke (Oppenheim et al. 2000) due to the presence of susceptibility
artifacts from basal skull. Risk of hemorrhagic transformation is one feared complication and
frequently asked question, especially when thrombolysis is contemplated. It had been
postulated that a DWI lesion volume > 100cm3 was highly associated with hemorrhagic
transformation, in particular when there was no associated DWI-PWI mismatch, hence
contraindication to thrombolysis. However this would require further study for confirmation.
Mixed results had been shown regarding the accuracy of baseline DWI in determination of
final infarct volume. While it was widely thought that it would underestimate the final size of
infarction (Yamada et al. 2002), Warach et al. (2000) in his double-blinded placebo-controlled
study involving patients suffering from anterior-circulation stroke syndromes, found that
baseline DWI lesion volume significantly correlated with baseline National Institute of Health
Stroke Scale (NIHSS) scores and follow-up lesion volume at 12 weeks. Therefore, it is well
established that DWI is accurate and superior to CT for diagnosis of acute ischemic stroke and
can probably predict baseline clinical stroke severity as well as final lesion volume.
3. Perfusion-weighted imaging
PWI provides information on hypoperfused area and momentary hemodynamic state of the
brain tissue before structural brain tissue damage, therefore to identify areas of reversible
ischemia early before it progresses to permanent infarction. It can be performed by exogenous
method (dynamic or steady state susceptibility contrast-enhanced MR imaging by injection of
MR contrast) or by endogenous method (arterial spin labeling by magnetically tagging water
protons in arterial blood).
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3.1. Mechanism
Dynamic susceptibility contrast-enhanced MR perfusion imaging involves rapid imaging with
gradient echo or spin echo echo-planar imaging during the first passage of a paramagnetic
contrast agent through the entire brain. 10 to 20 brain slices are usually repeatedly imaged
immediately before and for 70 to 80 seconds after contrast injection, with 20 to 40 images per
slice obtained. It makes use of the tissue signal changes caused by susceptibility (T2*) effects
to generate signal drop (shortening of T2 and T2*) and creates a hemodynamic time-signal
intensity curve for each voxel, which in turns depends on cerebral blood volume and cerebral
blood flow (Seevinck et al. 2010). It is through the dynamic monitoring of these signal changes
in perfused tissue that hemodynamic parameters can be estimated. In contrary, steady state
susceptibility contrast-enhanced MR perfusion allows estimation of blood volume, micro-
vessel density and vessel size from the contrast-induced signal changes. Spin echo and gradient
echo transverse relaxation rates are measured before and after contrast injection, typically with
use of ultrasmall superparamagnetic iron oxide particles (longer half-life and higher suscept‐
ibility difference) from which parameters are derived (Wu EX et al. 2004). This method
however is mainly of use in research level only.
Quantification depends on measuring the signal intensity change within tissues which itself
is the susceptibility effect of the contrast agent. The ram images are processed on a pixel-by-
pixel basis to generate perfusion maps of different parameters. Time-to-peak (TTP) can be
readily obtained by simple data processing from the tissue response curve. Cerebral blood
flow (CBF), cerebral blood volume (CBV) and mean transit time (MTT) are time dependent
parameters requiring utilization of computational deconvolution methods (such as singular
value decomposition, circular value decomposition, Fourier transformation) with knowledge
of arterial input function for quantification. The arterial input function is defined under visual
control by drawing 5-10 intravascular voxels within the proximal & distal segments of the
concerned artery of the unaffected hemisphere (Zaro-Weber et al. 2010a). Point to note is that
these are relative values only due to variable confounding factors which will be discussed in
later section.
Arterial spin labeling is a non-invasive method exploiting the spins of endogenous water
protons to measure perfusion without the need of gadolinium. An inversion radiofrequency
pulse is used to tag & invert the spin polarity of the flowing arterial protons with respect to
stationary arterial proton, at a level proximal to the imaging slab (Deibler et al. 2008). The
tagged spins then enter the imaging plane and exchange with tissue, allowing pair-wise
subtraction to yield the perfusion map after acquisition of multiple runs for signal intensity
averaging. The detected MR signals would be analyzed and perfusion parameters can be
obtained. However, it has a low signal-to-noise ratio requiring longer imaging time.
3.2. Image analysis
Perfusion imaging is the method of choice for demonstrating ischemic brain tissue in hyper‐
acute stage of stroke. The central portion with maximal perfusion abnormality will progress
irreversibly to infarction while the outer area with only slight perfusion abnormality may
recover (Hossmann 1994; Rohl et al. 2001). No single threshold has thus far been able to reliably
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discriminate salvageable from unsalvageable tissue definitely (Wu O et al. 2006) since absolute
quantification of cerebral perfusion is not really possible and perfusion thresholds change with
time (Butcher et al. 2003). Interpretation is based on the concept that as CBF falls, CBV is initially
unchanged or increased (from vasodilatation due to autoregulation) in conjunction with
prolonged MTT and TTP. If such autoregulatory mechanism is exhausted, CBV will then
decrease and CBF continues to fall to a level of irreversible ischemia with eventual infarction.
Therefore a mismatch between MTT/TTP and CBV or CBF map indicates presence of poten‐
tially salvageable tissue (Figure 2).
 
(a) CBF 
map 
(b) CBV map 
(c) MTT map (c) TTP map 
Figure 2. Patient with right internal carotid artery (ICA) occlusion shows mild reduced a) CBF & b) CBV; but marked
elevated c) MTT & d) TTP along right ICA territory.
3.3. Parameters threshold
Depending on different processing methods, differing results regarding the reliability and
threshold of each parameter resulted. MTT or TTP delay relative to the contralateral hemi‐
sphere has been used in preference to CBF & CBV because of the more conspicuous changes
and better correlation with initial stroke severity and change in infarct size, hence final
functional outcomes in individual patient (Kane et al. 2007; Muir et al. 2006). In the contrary,
pre-treatment lesions on DWI and ADC maps were non-discriminative.
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3.3.1. Time-to-peak (TTP)
Restrepo et al. (2004) found that TTP map was most useful in demonstrating perfusion changes,
showing good signal-to-noise ratio facilitating identification of lesion boundary, rendering it
a parametric surrogate marker for efficacy of acute stroke treatment. A perfusion delay of 6
seconds relative to the non-affected hemisphere on TTP maps acquired before the initiation of
stroke treatment helped predict the lesion size on T2-weighted images on day 8 irrespective
of the treatment regimen (Kidwell et al. 2002; Nighoghossian et al. 2003; Seitz et al. 2005).
Neumann-Haefelin et al. (1999) reported a TTP delay of >6 seconds best predicted final infarct
volume while a TTP delay >4 seconds correlated best with acute stage neurologic deficit,
signifying the true penumbra lies between 4 to 6 seconds. Kajimoto et al. (2003) depicted same
result with a TTP delay of >4 seconds (sensitivity 79%, specificity 96%) in his study evaluating
patients with chronic stroke. Sobesky et al. (2004 & 2005) validated these threshold values in
patients with acute stroke, and demonstrated matched results when comparing with PET-
derived data, also showing a TTP delay threshold of >4 seconds with sensitivity of 84% &
specificity of 77%, and a penumbral volume threshold of >6 seconds. Takasawa et al. (2008)
later reported a TTP delay threshold of >4.8 seconds which is also similar, as supported more
recently, by Zaro-Weber et al. (2010a) showing a TTP delay threshold of >4.2 seconds best
predicted penumbral flow, with a sensitivity of 91% and specificity of 82%. These consistent
findings strengthen the TTP delay threshold to lie between >4-5 seconds.
3.3.2. Mean transit time (MTT)
Grandin et al. (2001 & 2003) reported a MTT delay of 8.1 seconds best predicted infarct growth
whereas a MTT delay of 5.3 seconds defined the hypoperfused area that did not progress to
infarction, to indicate oligemic tissue. Yamada et al (2002) supported the accuracy of MTT maps
showing a sensitivity of 85-94% and positive predictive value of 54-61% for final infarct
volume. Such results were in coherent with other studies, with Parsons et al. (2002) depicting
a >6 seconds threshold, Bristow et al. (2005) depicting a >7seconds threshold, Takasawa et al.
(2008) depicting a> 6-7 seconds threshold, and more recently, Zaro-Weber (2010a) demon‐
strating a >5.3 seconds threshold with a sensitivity of 88% & specificity of 78%. Therefore, we
can conclude that a MTT delay between 5.3 -8.1 seconds denotes the true penumbra.
3.3.3. Cerebral blood flow (CBF)
CBF has found to be a good indicator of penumbral flow. Early study by Liu et al. (2000)
revealed a cut off value of 48% of the unaffected hemisphere for depiction of penumbral flow.
From positron emission tomography (PET) scan, it was found that neurological dysfunction
occurred after CBF dropped below 20mL/100g of brain tissue per minute while infarction
occured shortly after CBF dropped below 10mL/100g of brain tissue per minute (Latchaw et
al. 2003). Zaro-Weber et al. confirmed in two of his recent trials (2009 & 2010a) that threshold
values of <20mL/100g/min (sensitivity 76%, specificity 96%) and <21.7mL/100g/min (sensitiv‐
ity 89%, specificity 87%) respectively were of best estimate of penumbral flow, adding to its
consistency and strength in validation. Therefore, a CBF between 10 -20mL/100g of brain tissue
per minute becomes the intermediate zone and represents penumbral flow.
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3.3.4. Cerebral blood volume (CBV)
CBV shows the least correlation with penumbral flow with limited studies validating its
penumbral threshold level in past literatures, especially in comparison with PET. Liu et al.
(2000) depicted the threshold level to be 87% of the unaffected hemisphere while Hatazawa et
al. (1999) found the threshold level to be 85% in their studies comparing with single photon
emission CT (SPECT). Zaro-Weber et al. (2010a) recently, in the only study comparing with
PET, found the penumbral threshold flow at <1.5mL/100g with a sensitivity of 82% and
specificity of 79%.
4. Diffusion-weighted — Perfusion-weighted imaging
Ischemia is a complex and multifactorial  process.  Its clinical severity on initial  presenta‐
tion is a major determinant of clinical outcome, correlating strongly with the extent of the
lesion. Proportion of patients with diffusion/perfusion mismatch and its size will depend
on the severity of stroke and time delay to imaging. Based on the heterogeneity of the ADC
and PWI values in depiction of ischemic lesion (Bandera et al. 2006), as well as occasion‐
al  recovery  of  DWI-abnormal  tissue  (Davis  & Donnan 2005),  it  becomes  clear  that  it  is
unlikely any single DWI or PWI parameters or threshold values will reliably predict the
degree of ischemia or infarct. Combination of diffusion- and perfusion-weighted imaging
has revolutionized acute stroke imaging, allowing early & accurate delineation of the actual
ischemic lesion or penumbra. Diffusion-perfusion mismatch is a quantitative and reliable
measure  with  important  pathophysiologic  &  therapeutic  implications,  becoming  the
surrogate of ischemic penumbra that provides valuable information for neurointervention
planning, especially within the crucial therapeutic window. The Desmoteplase for Acute
Ischemic Stroke and Dose Escalation of  Desmoteplase for Acute Ischemic Stroke studies
demonstrated  that  patients  with  PWI-DWI  mismatchs  who  were  treated  with  desmote‐
plase experienced higher rate of reperfusion and better clinical outcome (Furlan et al. 2006;
Hacke et  al.  2005).  Earlier  studies  by Parsons et  al.  (2001 & 2002)  demonstrated greater
recanalization, reperfusion and penumbral salvage in a group of patients with DWI-PWI
mismatch compared with the control group in acute stroke patients treated with intrave‐
nous tissue plasminogen activator. Luby & Warach (2007) also found that mismatch volumes
can provide  highly  reliable  and consistent  results  with  improved sensitivity.  Early  PWI
lesions are typically larger than early DWI lesions. Finding of normal diffusion-weighted
images  and altered  perfusion  parameters  (mismatch)  is  a  simple  and practical  mean to
define the tissue at  risk,  which correlates with poor clinical  outcome (Derex et  al.  2004;
Parsons et al. 2002). If untreated or reperfusion does not occur, progressive enlargement of
the DWI lesion over time is expected, signifying progressive infarction of the initial PWI
lesion. This can be rapid in patient with poor collateral circulation. Conversely, a pattern
of DWI lesion equaling the volume of  PWI lesion indicates absence of  penumbra or no
salvageable tissue.
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5. Reliability and pitfalls
The reliability of mismatch volume and percentage of measurements had been discussed
though not extensively investigated. Obtaining precise parameters is one major problem as
only the “relative” but not absolute perfusion changes can be measured due to presence of
significant confounding factors, hence nowadays we mostly rely on the relative maps of
perfusion. So, exactly how precise can the penumbral threshold be quantitatively estimated
by CBF, CBV, TTP and MTT? What are the overall accuracy, reproducibility and reliability?
Firstly, perfusion imaging is sensitive to vascular delays (tracer arrival delay and tissue transit
time) and dispersion effects (Calamante et al. 2002), especially in the derivation of the nonde‐
convoluted TTP map. Any minor physiologic change such as heart rate and cardiac output can
potentially change the mismatch zone. Lack of standardization between MR machines,
measurement technique or associated errors from pulse sequence parameters, image process‐
ing and analytic software are other major concerns. Measurement of arterial input function is
particularly problematic with lack of standardized protocol in measurement of signal intensity
around the artery. Besides, the tissue signal intensity does not demonstrate a linear relationship
to tissue contrast concentration (Latchaw et al. 2003). Past studies attempted to optimize
perfusion maps by venous output function (Knutsson et al. 2007), separated measurement of
CBV (Newman et al. 2003), advanced mathematical correction (van Osch et al. 2003), partial
volume artifact correction, and bulk-blood correction (Zaharchuk et al. 2009) but were found
technically difficult requiring further validation.
We have to understand that considerable individual variation regarding the penumbral flow
exists and absolute quantification of the perfusion maps is difficult. So far, perfusion maps had
been mainly validated with respect to infarct delineation on follow-up MR imaging but with
uncertainty of perfusion changes during the time interval in between (Zaro-Weber et al.
2010a). Improved validation had been made by direct comparison with PET for in vivo
perfusion measurement in normal subjects and chronic cerebrovascular dusease, but with only
few in acute stroke setting (Grandin et al. 2005; Ibaraki et al. 2007; Lin et al. 2001; Ostergaard
et al. 1998; Tanaka et al. 2006), raising uncertainty that such values may not precisely demon‐
strate the exact tissue at greatest risk of infarction, hence leading to misleading & unreliable
interpretation (Keir & Wardlaw 2000). Despite so, PET-based calibration of perfusion imaging
demonstrated superior result with best correction of the absolute perfusion values. Neverthe‐
less, different post-processing algorithms differ, producing variations in lesion size and
measured parameters. Indeed, ideal technique of perfusion imaging and its post-processing
have not yet established. Zaro-Weber et al. (2010b) found that the variation of penumbral flow
for each patient was high and hence with great error, emphasizing the need for an individual
correction procedure or calibration with independent cohort. In a later study, he also found
that the mean flow rate on contralateral hemisphere well explained the variability of individual
perfusion thresholds such that it could be used to yield the best estimate of penumbral
threshold. Based on these, a PET-validated look-up table was derived to calibrate the best
individual penumbral threshold from the values of the contralateral hemispheric reference,
allowing a much improved volumetric congruence. Linear regression analysis demonstrated
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best agreement for TTP and good agreement for CBF and MMT while that for CBV was less
pronounced. Despite this seemingly advantage, further validation (especially in an independ‐
ent cohort) will be needed before its implementation in clinical use. In the meantime, stand‐
ardization in both the data processing methods and software is also much needed. A consensus
on which parameter is best to be used for prediction should also be made.
Arterial spin labeling has additional limitation regarding its own method, in that assumptions
on tagging efficiency, delay time to imaging and flow quantification are based on normal
population. Whether the same setting can be translated to various disease states has yet to be
tested properly (Deibler et al. 2008). Besides, it has a relatively low signal-to-noise ratio, further
adding to uncertainty in its accuracy. Therefore dynamic contrast enhanced susceptibility MR
imaging technique is still the preferred method for quantitative perfusion imaging.
6. Transient ischemic attack
Transient ischemic attack should not be taken lightly as it carries a subsequent risk of ischemic
stroke of 10% within 7 days and 30% within 90 days of symptoms onset, in particularly during
the first 48 hours (Johnston et al. 2000; Mlynash et al. 2009). Subsequent risk of myocardial
infarction, arrhythmia and congestive heart failure are increased. Hence appropriate preven‐
tion strategy is important in reducing the risk.
Establishment of the diagnosis of transient ischemic attack has been a major challenge since
most patient present normal neurologically with resolution of the clinical deficit at the time of
consultation and imaging, resulting in negative finding on conventional MR brain imaging.
DWI & PWI can provide objective measurement of brain ischemia, even better than angiog‐
raphy as lesions are mostly small and may reflect occlusion of distal intracranial vessels that
is angiographically occulted. Past studies demonstrated variable lesion depiction rate from 16
to 67% on DWI in patients with TIA (Crisostomo et al. 2003; Kastrup et al. 2002; Kidwell et al.
1999; Krol et al. 2005; Redgrave et al. 2007; Restrepo et al. 2004; Rovira et al. 2002) but it had
been argued that these patients should be labeled as ischemic stroke with infarction rather,
regardless of the duration of symptoms with a clinical implication of potential poorer clinical
outcome. This was still much debatable as report had described complete resolution of both
DWI and PWI abnormalities on follow-up images (Kidwell et al. 1999; Neumann-Haefelin et
al. 2000; Rovira et al. 2002). Initial studies had also found that approximately one-thirds of the
DWI lesions would normalized to a certain degree if they were imaged within a 3 hour time
window (Fiehler et al. 2002; Kidwell et al. 2000). PWI should substantiate the yield given its
ability to reveal hypoperfusion accompanying or preceding development of DWI abnormali‐
ties. Nevertheless, the occurrence of patients with positive PWI and negative DWI was
variable, reported to be 3 to 33% (Krol et al. 2005; Mlynash et al. 2009; Restrepo et al. 2004).
Ma et al. (2009) explained in his study model that the classical mismatch pattern would
fragment with time due to a number of more random events such as variable ages & compo‐
sition of the clots, random locations of vessel occlusion with consequent differences in
vulnerability of tissue, and variable degree of collateralization from neighboring vessels.
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Therefore, the yield is expected to be >50% if such patients are scanned urgently after symptom
onset. It is useful in helping to identify a subset of patients with diffusion-perfusion mismatch
who would require close observation, and possible further investigation such as angiography
assessment which would then have a high yield (>50%) for detection of potentially relevant
lesion, hence to assist in subsequent management. It helps to differentiate those that who are
likely to improve or reverse spontaneously from those who are likely to progress.
7. Clinical impact
There is no true imaging gold standard in acute stroke. DWI has a well established role in
depiction of acute infarction while it is also clear that perfusion imaging can provide infor‐
mation that cannot be depicted in other techniques, thus seemingly superior. After all, is there
a role for perfusion imaging in affecting clinical decision making and hence, influencing patient
outcomes? Previously, we have already discussed that perfusion-diffusion mismatch corre‐
lates with poor clinical outcome and that treatment of large perfusion-diffusion mismatch can
result in improved clinical outcome. Such can lead to the attracting prospect of expanding the
narrow therapeutic time window by selecting eligible patients via DWI-PWI mismatch, as
demonstrated in various series & trials (Albers et al. 2006; Davis et al. 2008; Furlan et al. 2006;
Hacke et al. 2005 & 2009; Parsons et al. 2002; Schellinger et al. 2007), but with lack of proper
prospective study or strong evidence-based validation so far to support its role in alteration
of patient outcomes. Beside, the exact role of perfusion imaging was often vague and its
benefits in decision making were usually under-evaluated or retrospectively compared with
clinical parameters only (Provenzale et al. 2008). Further, it is not yet established that patients
without mismatch will be unresponsive to thrombolysis, since DWI lesions can potentially
resolve as discussed previously. More importantly, nowadays in most stroke centers, decisions
for administration of thrombolytic agents in patients suffering from acute ischemic stroke are
often made without prior perfusion imaging, nor even diffusion imaging. Decisions are
routinely made on clinical ground in particular for those presenting at <4.5 hours, raising
doubts over its added value. This is perhaps the main reason for lack of literature addressing
the influencing role of perfusion imaging in decision making of thrombolysis. In addition, the
feasibility and practicality of MR imaging in acute stroke assessment are always in doubt.
Cleary, time is an important factor. The whole process of perfusion imaging together with
subsequent data analysis can be time-consuming especially in less experience hands. After all,
routine use of PWI to assess acute ischemic stroke is open to dispute. Until we have a com‐
pelling randomized prospective blinded study assessing the efficacy of perfusion imaging in
decision making in assessment of acute ischemic stroke, perhaps the most convincing role at
present is prediction of final infarct volume which demonstrates strong correlation, and hence
helping to predict the clinical outcome in individual patient. On the other hand, it can also be
of great use in monitoring of evolution of ischemia and subsequent therapeutic response.
Despite these seemingly limitations and arguments on methodical issues, many believe that
the accumulated evidence of the importance of DWI-PWI mismatch is already good enough
to establish a role in daily practice if allow.
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8. Conclusion
With advances in imaging technology, there is substantial evidence and data to support the
feasibility & superiority of MR imaging in acute ischemic stroke. PWI is complementary to
DWI in acute stroke assessment. DWI-PWI mismatch provides a good, rapid & reliable
estimation of the penumbra, helping to select suitable candidate for acute thrombolytic
therapy, especially for patients presenting with unknown onset time or beyond the 4.5 hours
therapeutic window. PWI lesion can resolve rapidly after successful thrombolysis or reperfu‐
sion, leading to improved clinical outcome. Only then will we know for every individual
patient, at certain time after stroke, with particular clinical features and parameters on DWI/
PWI, which will be the best clinical management.
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